Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
Karp, J. E., Garrett-Mayer, E., Estey, E. H., Rudek, M. A., Smith, B. D., Greer, J. M., Drye, D. M., Mackey, K., Dorcy, K. S., Gore, S. D., Levis, M. J., McDevitt, M. A., Carraway, H. E., Pratz, K. W.Volume:
97
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2012.062539
Date:
November, 2012
File:
PDF, 442 KB
english, 2012